We believe there’s a very compelling case for small-cap stocks today. Of course, it’s still a very murky picture, and impossible to predict if the bottom of the market is truly behind us. However, a speedy and massive response from central banks and governments worldwide and improving health care data have combined with extremely oversold markets to catalyze a stock market surge that began on March 24. Historically, small-caps have tended to outperform large caps in the early days of a new bull market, and small-cap valuations look very attractive relative to large-cap stocks as well.
That said, not all companies will thrive despite the expansive stimulus and supportive Fed programs that have been put into place. Given the macro uncertainty and many moving parts in the market, we believe a selective and active approach are key to unlocking small-cap opportunities, with greater market inefficiencies in small-cap investing making manager skill that much more essential.
We have currently positioned Calamos Timpani Small Cap Growth Fund (CTSIX) with select exposure to high quality cyclical growth names that can benefit from a rebounding economy. However, we remain tilted to high quality secular growth stocks with low debt levels and above average earnings visibility. Many of CTSIX’s holdings are benefiting from thematic tailwinds that we believe will become more powerful as trends emerge in the wake of COVID-19. Even when the pandemic passes, we believe these trends will endure.
(Note: please refer to the disclosures for additional information about the portfolio holdings that will be discussed below.)
The small-cap space has long been the home of many innovative companies, some of which have grown into large-cap market leaders. As the world adapts to the challenges created by COVID-19, we see small-cap companies providing compelling solutions that create investment opportunities. Our fundamental research has led us to many stocks in this less-followed area of the stock market that can potentially benefit in this new world.
Largest holdings as of 3/31/2020: | % of Net Assets |
---|---|
eHealth, Inc. | 4.6% |
Amedisys, Inc. | 3.2% |
RingCentral, Inc. - Class A | 2.9% |
Palomar Holdings, Inc. | 2.2% |
Lattice Semiconductor Corp. | 2.0% |
LHC Group, Inc. | 1.9% |
Advanced Energy Industries, Inc. | 1.9% |
Five9, Inc. | 1.9% |
Mercury Systems, Inc. | 1.9% |
Inspire Medical Systems, Inc. | 1.8% |
The Fund is actively managed. Holdings and weightings are subject to change daily. Holdings are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities mentioned.
As of 2/28/2020, the Fund held the following weighting (percent of investments) in the securities discussed above as follows: RingCentral, 3.01%; eHealth, 3.0%; Five9, 2.47%; Everbridge, 2.66%; Amedisys, 2.05%; Teladoc, 1.83%; Yeti, 1.79%; Lattice Semiconductor, 1.64% Diodes, 1.26%; Phreesia, 1.22%; LHC Group, 1.04%; Nice, 1.03%; LHC, 1.04%; Chegg, 1.01%; Axon Enterprises, 0.97%; Varonis Systems, 0.93%; Shotspotter, 0.87%; Ping Identity, 0.76%; AudioCodes, 0.75%; SiTime, 0.75%; Addus Homecare, 0.74%; FTI Consulting, 0.68%; The Rubicon Project, 0.64%; Itamar Medical, 0.49%.
Before investing, carefully consider the fund’s investment objectives, risks, charges and expenses. Please see the prospectus and summary prospectus containing this and other information which can be obtained by calling 1-866-363-9219. Read it carefully before investing.
Opinions are subject to change due to changes in the market, economic conditions or changes in the legal and/or regulatory environment and may not necessarily come to pass. This information is provided for informational purposes only and should not be considered tax, legal, or investment advice. References to specific securities, asset classes and financial markets are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations.
Important Risk Information. An investment in the Fund(s) is subject to risks, and you could lose money on your investment in the Fund(s). There can be no assurance that the Fund(s) will achieve its investment objective. Your investment in the Fund(s) is not a deposit in a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation (FDIC) or any other government agency. The risks associated with an investment in the Fund(s) can increase during times of significant market volatility. The Fund(s) also has specific principal risks, which are described below. More detailed information regarding these risks can be found in the Fund's prospectus.
The principal risks of investing in the Calamos Timpani Small Cap Growth Fund include: equity securities risk consisting of market prices declining in general, growth stock risk consisting of potential increased volatility due to securities trading at higher multiples, and portfolio selection risk. The Fund invests in small capitalization companies, which are often more volatile and less liquid than investments in larger companies. As a result of political or economic instability in foreign countries, there can be special risks associated with investing in foreign securities, including fluctuations in currency exchange rates, increased price volatility and difficulty obtaining information. In addition, emerging markets may present additional risk due to potential for greater economic and political instability in less developed countries.
18786 0420O R